Serum cardiac troponin elevation predicts mortality in patients with pulmonary hypertension: A meta‐analysis of eight cohort studies
Open Access
- 13 January 2019
- journal article
- review article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 13 (2) , 82-91
Abstract
Objective: To determine the association of serum cardiac troponin (cTn) with the mortality of pulmonary hypertension (PH) patients via a meta‐analysis.Date Source: We searched PubMed and EMBASE from inception to October 25, 2017.Study Selection: The reference lists of the retrieved articles were also consulted. The Q test and I2 test were used for to assess heterogeneity. The relationship between cTn elevation and mortality was analysed. Studies were stratified according to type of troponin (cTnT vs cTnI), region (Europe vs America) and follow‐up length (≤3 years vs >3 years).Results: Eight studies with 739 patients were included in the meta‐analysis. Cardiac troponin elevation ranged from 14.3% to 94.5%. Overall, 48.8% (39/80) of patients with elevated cTn died compared to 18.6% (45/242) of patients with normal cTn levels. These findings showed cTn elevation was significantly related to an increased mortality risk in PH patients [hazard ratio (HR) = 3.05, 95% confidence interval (95% CI) = 2.16‐4.32, I2 = 24.9%]. cTnI was better at predicting mortality than cTnT (HR = 3.37, 95%CI = 2.05‐5.55 vs HR = 2.80, 95%CI = 1.97‐3.98, respectively). American populations had increased mortality compared to European populations (HR = 4.23, 95%CI = 2.29‐7.80 vs HR = 2.70, 95% CI = 1.95‐3.74, respectively). This finding was independent of the follow‐up length of the studies (≤3 years: HR = 2.36, 95%CI = 1.65‐3.38; >3 years: HR = 4.55, 95%CI = 2.80‐7.39).Conclusions: Although different studies detected the expression cTnT or cTnI by various methods, the mortality in the cTn‐positive group was higher than that in the cTn‐negative group. Serum cTn elevation emerged as an independent predictor of increased risk of mortality in PH patients.Keywords
Funding Information
- The National Natural Science Foundation of China (81560694, 81760015 and 81360049)
- Yunnan Health Training Project of High Level Talents (D-201627)
- Young academic and technical leaders of Yunnan Province (2017HB053)
This publication has 27 references indexed in Scilit:
- Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New ZealandHeart, Lung and Circulation, 2018
- Acute decompensated pulmonary hypertensionEuropean Respiratory Review, 2017
- Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionEuropean Respiratory Journal, 2017
- Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertensionCardiology Journal, 2016
- Special Situations in Pulmonary HypertensionCardiology Clinics, 2016
- A global view of pulmonary hypertensionThe Lancet Respiratory Medicine, 2016
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Comparison of Brain Natriuretic Peptide (BNP) and NT-proBNP in Screening for Pulmonary Arterial Hypertension in Patients with Systemic SclerosisThe Journal of Rheumatology, 2010
- High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertensionClinical Science, 2010
- Measuring inconsistency in meta-analysesBMJ, 2003